scholarly journals Secukinumab dosing every two weeks demonstrated superior efficacy compared with dosing every four weeks in patients with psoriasis weighing 90 kg or more: Results of a randomised controlled trial

Author(s):  
Matthias Augustin ◽  
Kristian Reich ◽  
Paul Yamauchi ◽  
Andreas Pinter ◽  
Jerry Bagel ◽  
...  
2012 ◽  
Author(s):  
Sarah Clement ◽  
Adrienne van Nieuwenhuizen ◽  
Aliya Kassam ◽  
Ian Norman ◽  
Clare Flach ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document